ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) from a sell rating to a hold rating in a research report released on Monday morning, reports.

According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. “

Separately, ValuEngine upgraded ASPEN PHARMACAR/ADR from a sell rating to a hold rating in a research note on Wednesday, October 2nd.

ASPEN PHARMACAR/ADR stock opened at $8.04 on Monday. The stock’s fifty day moving average price is $6.69 and its two-hundred day moving average price is $6.48. ASPEN PHARMACAR/ADR has a one year low of $4.14 and a one year high of $11.36.


Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Get a free copy of the Zacks research report on ASPEN PHARMACAR/ADR (APNHY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with's FREE daily email newsletter.